Meeder Asset Management’s Molecular Templates, Inc. MTEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-371
Closed -$77K 2441
2020
Q2
$77K Buy
371
+109
+42% +$25.3K 0.01% 825
2020
Q1
$54K Sell
262
-44
-14% -$9.63K ﹤0.01% 887
2019
Q4
$65K Buy
306
+153
+100% +$22K ﹤0.01% 944
2019
Q3
$15K Sell
153
-272
-64% -$25.4K ﹤0.01% 1413
2019
Q2
$53K Buy
425
+325
+325% +$35.3K ﹤0.01% 944
2019
Q1
$9K Sell
100
-165
-62% -$12.1K ﹤0.01% 1280
2018
Q4
$17K Buy
265
+145
+121% +$10.1K ﹤0.01% 1112
2018
Q3
$9K Buy
+120
New +$9.2K ﹤0.01% 1197

Other funds holding MTEM

Meeder Asset Management's MTEM Position: Q3 2020 in Review

Meeder Asset Management sold out of Molecular Templates, Inc. (MTEM) in Q3 2020, closing a stake of 371 shares — an estimated $77K sold.

Meeder Asset Management first reported a position in MTEM in Q3 2018 and held it in 8 quarters. The position peaked at $77K in Q2 2020. 103 funds tracked by Wall St. Rank hold MTEM as of Q3 2020.

  • Meeder Asset Management reported no remaining Molecular Templates, Inc. position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 371 Molecular Templates, Inc. shares in Q3 2020, an estimated $77K.
  • Meeder Asset Management first reported a position in Molecular Templates, Inc. in Q3 2018 and held it in 8 quarters.
  • Meeder Asset Management's Molecular Templates, Inc. position peaked at $77K in Q2 2020.
  • 103 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.